In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Annular sizing for transcatheter aortic valve selection. A comparison between computed tomography and 3D echocardiography.

Session Poster session 3

Speaker Maria Joao Andrade

Congress : EuroEcho-Imaging 2015

  • Topic : interventional cardiology and cardiovascular surgery
  • Sub-topic : Non-coronary Cardiac Intervention
  • Session type : Poster Session
  • FP Number : P695

Authors : S Madeira (Carnaxide,PT), R Ribeiras (Carnaxide,PT), J Abecasis (Carnaxide,PT), R Teles (Carnaxide,PT), M Castro (Carnaxide,PT), A Tralhao (Carnaxide,PT), E Horta (Carnaxide,PT), J Brito (Carnaxide,PT), M Andrade (Carnaxide,PT), M Mendes (Carnaxide,PT)

S Madeira1 , R Ribeiras1 , J Abecasis1 , R Teles1 , M Castro1 , A Tralhao1 , E Horta1 , J Brito1 , M Andrade1 , M Mendes1 , 1Hospital de Santa Cruz - Lisbon - Portugal ,

Eur Heart J Cardiovasc Imaging Abstracts Supplement ( 2015 ) 16 ( Supplement 2 ), ii114

Introduction: Tri-dimensional imaging techniques such as CT angiography (CT) and 3D transesophageal echocardiography (3D TEE) have been used to study the anatomy, size and calcification of the aortic annulus before transcatheter aortic valve implantation (TAVI).

Aim: To compare the measurements and agreement of different imaging modalities in valve selection: CT (using two different softwares, the Osirix 32bit version and 3Mension (3M) 2.0 version) and 3D TEE (Philips - 3DQ - MPR).

Methods: Single centre retrospective analysis of 20 patients in whom both CT and 3D TEE were used to study the annulus before TAVI. Three independent observers were blinded to each other and to the type of implanted prosthesis (16 auto-expandable and 4 balloon expandable). The following annulus variables were compared: orthogonal diameters in the sagittal and coronal planes, area, perimeter and mean diameter. The correlation analysis between the different methods was performed using the Spearman coefficient. The inter-method measurement differences were assessed by the Wilcoxon and Sign tests.

Agreement was assessed by the construction of Bland-Altman plots.

Results: There was a good correlation between CT measurements using Osirix and 3M (r >.74 p < 0.02). The correlation was moderate between the measurements of CT and 3D TEE (r 0.46/0.66 for sagittal diameter/area and intermediate in the remaining variables p <0,05) and it was slightly superior for the 3M measurements. The 3D TEE measurements were significantly inferior than the CT ones, with the exceptions for the sagittal diameter in all comparisons (p<0.142) and for the coronal diameter when compared to the 3M results (p=0.064) (Table)

Conclusion: The aortic annular diameters and areas measured by CT (Osirix, 3M) and 3D TEE (MPR) showed a fair correlation. Measurements by 3D TEE were significantly inferior, except for sagittal diameter (measured by CT- 3M and 3D TEE – MPR), which was the most consistent variable among the three modalities.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are